184 related articles for article (PubMed ID: 21116710)
1. Arrhythmic complication in cardiorenal syndrome.
Padeletti L; Innocenti L; Paoletti Perini A; Gronda E
Heart Fail Rev; 2011 Nov; 16(6):569-73. PubMed ID: 21116710
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
[TBL] [Abstract][Full Text] [Related]
3. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
5. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
7. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
8. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
Wu KC
Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
[TBL] [Abstract][Full Text] [Related]
9. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
[TBL] [Abstract][Full Text] [Related]
10. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?
Wheeler M; Grigg L; Zentner D
Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816
[TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac death in dialysis: do current guidelines for implantable cardioverter defibrillator therapy apply to patients with end-stage kidney disease?
O'Shaughnessy MM; Lappin DW; Reddan DN
Semin Dial; 2012 May; 25(3):272-6. PubMed ID: 22452711
[TBL] [Abstract][Full Text] [Related]
12. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
[TBL] [Abstract][Full Text] [Related]
13. Management and outcomes of hypertrophic cardiomyopathy in young adults.
Baron É; Karam N; Donal E; Puscas T; Mirabel M; Bacher A; Wahbi K; Mazzella JM; Jeunemaitre X; Reant P; Hagège A;
Arch Cardiovasc Dis; 2021; 114(6-7):465-473. PubMed ID: 33744178
[TBL] [Abstract][Full Text] [Related]
14. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
[TBL] [Abstract][Full Text] [Related]
15. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
16. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients.
Zhou Y; Zhao S; Chen K; Hua W; Zhang S
BMC Cardiovasc Disord; 2019 May; 19(1):129. PubMed ID: 31146684
[TBL] [Abstract][Full Text] [Related]
20. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
